Loading...
XTAE
GEFR
Market cap29mUSD
May 22, Last price  
48.30ILS
1D
-5.66%
1Q
-30.80%
IPO
-94.86%
Name

Geffen Residence & Renewal Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
80,422.82
EPS
—
Div Yield, %
—
Shrs. gr., 5y
94.80%
Rev. gr., 5y
%
Revenues
131k
-7.75%
0000017,916,000658,00060,000142,000131,000
Net income
-5m
L-26.58%
-1,516,000-140,000-3,076,000-851,000-9,380,000-8,809,000-13,426,000-20,082,000-6,910,000-5,073,000
CFO
-16m
L-73.29%
-16,230,000-557,000-1,474,0002,000-4,288,000-6,236,000-15,190,000-11,173,000-61,458,000-16,415,000
Dividend
Sep 30, 20156.6337 ILS/sh

Profile

Geffen Residence & Renewal Ltd engages in the cultivation, production, storage, marketing, and sale of medical cannabis in Israel. It owns pharmacies, which sell cosmetics, convenience, and toiletries, as well as pharmacy and natural products, such as marketing prescription drugs, over-the-counter drugs, natural products, and vitamins and supplements. The company also offers plasters and bandages; and thermometer and humidifiers. The company was formerly known as Cannomed Medical Cannabis Industries Ltd. The company was incorporated in 1999 and is based in Tel Aviv-Yafo, Israel.
URL
https://cannomed.com
IPO date
Feb 26, 2010
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
131
-7.75%
142
136.67%
60
-90.88%
Cost of revenue
4,089
2,870
8,706
Unusual Expense (Income)
NOPBT
(3,958)
(2,728)
(8,646)
NOPBT Margin
Operating Taxes
(1,077)
(499)
9,524
Tax Rate
NOPAT
(2,881)
(2,229)
(18,170)
Net income
(5,073)
-26.58%
(6,910)
-65.59%
(20,082)
49.58%
Dividends
Dividend yield
Proceeds from repurchase of equity
46,242
BB yield
Debt
Debt current
93
3,164
Long-term debt
45,036
45,276
213
Deferred revenue
Other long-term liabilities
485
Net debt
30,660
14,220
1,721
Cash flow
Cash from operating activities
(16,415)
(61,458)
(11,173)
CAPEX
(65)
(292)
(56)
Cash from investing activities
(65)
(292)
3,553
Cash from financing activities
(107)
91,150
(2,279)
FCF
(7,809)
(7,200)
1,022
Balance
Cash
14,469
31,056
1,656
Long term investments
Excess cash
14,462
31,049
1,653
Stockholders' equity
(45,930)
(15,887)
(11,412)
Invested Capital
145,749
118,953
19,006
ROIC
ROCE
EV
Common stock shares outstanding
256,250
215,636
99,386
Price
Market cap
EV
EBITDA
(3,619)
(2,210)
(5,997)
EV/EBITDA
Interest
284
48
404
Interest/NOPBT